Targeted kinase degradation via the KLHDC2 ubiquitin E3 ligase

被引:14
作者
Kim, Younghoo [1 ,2 ]
Seo, Pooreum [3 ]
Jeon, Eunhye [2 ]
You, Inchul [3 ]
Hwang, Kyubin [2 ]
Kim, Namkyoung [1 ,2 ]
Tse, Jason [3 ]
Bae, Juhyeon [2 ]
Choi, Ha-Soon [4 ]
Hinshaw, Stephen M. [3 ]
Gray, Nathanael S. [3 ]
Sim, Taebo [1 ,2 ]
机构
[1] Korea Univ, KU KIST Grad Sch Converging Sci & Technol, 145 Anam Ro, Seoul 02841, South Korea
[2] Yonsei Univ, Severance Biomed Sci Inst, Grad Sch Med Sci, Coll Med,Brain Korea Project 21, 50 Yonsei Ro, Seoul 03722, South Korea
[3] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA
[4] Magicbullettherapeutics Inc, 50 Yonsei Ro, Seoul 03722, South Korea
基金
新加坡国家研究基金会;
关键词
INHIBITORS; MOLECULES; PROTEINS; PROTACS;
D O I
10.1016/j.chembiol.2023.07.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chemically induced protein degradation is a powerful strategy for perturbing cellular biochemistry. The pre-dominant mechanism of action for protein degrader drugs involves an induced proximity between the cellular ubiquitin-conjugation machinery and a target. Unlike traditional small molecule enzyme inhibition, targeted protein degradation can clear an undesired protein from cells. We demonstrate here the use of peptide li-gands for Kelch-like homology domain-containing protein 2 (KLHDC2), a substrate adapter protein and mem-ber of the cullin-2 (CUL2) ubiquitin ligase complex, for targeted protein degradation. Peptide-based bivalent compounds that can induce proximity between KLHDC2 and target proteins cause degradation of the tar-geted factors. The cellular activity of these compounds depends on KLHDC2 binding. This work demon-strates the utility of KLHDC2 for targeted protein degradation and exemplifies a strategy for the rational design of peptide-based ligands useful for this purpose.
引用
收藏
页码:1414 / +
页数:13
相关论文
共 50 条
[41]   Ubiquitin-specific protease 19 regulates the stability of the E3 ubiquitin ligase MARCH6 [J].
Nakamura, Nobuhiro ;
Harada, Kumi ;
Kato, Masako ;
Hirose, Shigehisa .
EXPERIMENTAL CELL RESEARCH, 2014, 328 (01) :207-216
[42]   Implications of frequent hitter E3 ligases in targeted protein degradation screens [J].
Zhang, Xiaoyu ;
Simon, Gabriel M. ;
Cravatt, Benjamin F. .
NATURE CHEMICAL BIOLOGY, 2025, :474-481
[43]   SAG/RBX2/ROC2 E3 Ubiquitin Ligase Is Essential for Vascular and Neural Development by Targeting NF1 for Degradation [J].
Tan, Mingjia ;
Zhao, Yongchao ;
Kim, Sun-Jung ;
Liu, Margaret ;
Jia, Lijun ;
Saunders, Thomas L. ;
Zhu, Yuan ;
Sun, Yi .
DEVELOPMENTAL CELL, 2011, 21 (06) :1062-1076
[44]   The TRIM4 E3 ubiquitin ligase degrades TPL2 and is modulated by oncogenic KRAS [J].
Bansod, Sapana ;
Dodhiawala, Paarth B. ;
Geng, Yutong ;
Bulle, Ashenafi ;
Liu, Peng ;
Li, Lin ;
Townsend, Reid ;
Grierson, Patrick M. ;
Held, Jason M. ;
Adhikari, Hema ;
Lim, Kian-Huat .
CELL REPORTS, 2024, 43 (09)
[45]   Targeted Degradation of KRAS by an Engineered Ubiquitin Ligase Suppresses Pancreatic Cancer Cell Growth In Vitro and In Vivo [J].
Ma, Yihui ;
Gu, Yumei ;
Zhang, Qiang ;
Han, Yongqing ;
Yu, Shuangni ;
Lu, Zhaohui ;
Chen, Jie .
MOLECULAR CANCER THERAPEUTICS, 2013, 12 (03) :286-294
[46]   Ligandability of E3 Ligases for Targeted Protein Degradation Applications [J].
Belcher, Bridget P. ;
Ward, Carl C. ;
Nomura, Daniel K. .
BIOCHEMISTRY, 2023, 62 (03) :588-600
[47]   RNF4, a SUMO-targeted ubiquitin E3 ligase, promotes DNA double-strand break repair [J].
Galanty, Yaron ;
Belotserkovskaya, Rimma ;
Coates, Julia ;
Jackson, Stephen P. .
GENES & DEVELOPMENT, 2012, 26 (11) :1179-1195
[48]   The RNA-binding E3 ubiquitin ligase MEX-3C links ubiquitination with MHC-I mRNA degradation [J].
Cano, Florencia ;
Bye, Helen ;
Duncan, Lidia M. ;
Buchet-Poyau, Karine ;
Billaud, Marc ;
Wills, Mark R. ;
Lehner, Paul J. .
EMBO JOURNAL, 2012, 31 (17) :3596-3606
[49]   TAM receptors attenuate murine NK-cell responses via E3 ubiquitin ligase Cbl-b [J].
Chirino, Leilani M. ;
Kumar, Suresh ;
Okumura, Mariko ;
Sterner, David E. ;
Mattern, Michael ;
Butt, Tauseef R. ;
Kambayashi, Taku .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2020, 50 (01) :48-55
[50]   The E3 ubiquitin ligase SOCS-7 reverses immunosuppression via Shc1 signaling in hepatocellular carcinoma [J].
Huang, Peixin ;
Zhao, Zhiying ;
Chen, Yi ;
Yang, Biwei ;
Xia, Jinglin .
LABORATORY INVESTIGATION, 2022, 102 (06) :613-620